Building the Future of U.S. Pharmaceutical Manufacturing
High-quality oral solid dosage manufacturing powered by excellence, compliance, and innovation.
STRATEGIC ADVANTAGE
U.S. Market Access
Puerto Rico Pharmaceutical Hub
Puerto Rico Pharmaceutical Hub
Full FDA regulatory alignment and direct access to the U.S. pharmaceutical market.
Puerto Rico Pharmaceutical Hub
Puerto Rico Pharmaceutical Hub
Puerto Rico Pharmaceutical Hub
One of the most established pharmaceutical ecosystems globally.
Highly Skilled Workforce
Puerto Rico Pharmaceutical Hub
Highly Skilled Workforce
Engineers and professionals with extensive pharmaceutical manufacturing experience.
Services
Manufacturing
OSD Manufacturing (Tablets & Capsules)
Contract Manufacturing (CMO)
Consultancy and Operations
Technology Transfer
Packaging Operations (Blister & Bottling)
Advisory
Regulatory Support (FDA cGMP)
Commercialization Support
STRATEGY — ANDA ACQUISITION
PharmPR Inc. is currently in the process of acquiring ANDAs and pharmaceutical product rights.
Our strategy includes:
• Selection of high-value generic products
• Efficient technology transfer
• Scalable manufacturing and commercialization
QUALITY & EXCELLENCE
Excellence and Quality Without Compromise
Everything we produce is guided by the highest standards:
• FDA cGMP compliance
• Robust quality systems
• Data integrity and consistency
MEET OUR CEO
Eng. Yilda Acevedo - Chief Executive Officer (CEO)
Eng. Yilda Acevedo is an accomplished engineer and executive leader with a strong track record in pharmaceutical manufacturing strategy, industrial development, and operational execution.
Key Achievements:
• Led the strategic development of PharmPR Inc. as a pharmaceutical manufacturing initiative in Puerto Rico
• Directed high-level planning for ANDA acquisition and commercialization strategy
• Advanced industrial infrastructure initiatives aligned with U.S. pharmaceutical supply chain needs
• Successfully engaged in investor-level discussions and capital strategy development
• Built a vision-driven organization focused on quality, compliance, and scalability
Her vision
Her leadership is defined by technical excellence, strategic clarity, and execution discipline, positioning PharmPR as a future leader in U.S.-based pharmaceutical manufacturing.
COMMITMENT
We are committed to:
Strengthening domestic pharmaceutical manufacturing
Delivering high-quality and reliable medications
Operating with integrity, compliance, and excellence
